The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Oral Presentation(E) Pharmaceutical Health Care and Sciences

[29-13-am]Clinical Pharmacy 11, Pharmacotherapies (Cancer)/Others

Sun. Mar 29, 2026 9:30 AM - 11:30 AM JST
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Room 13 (C404, Bldg. 2, Area 2 [4F])
Chair: Takeo Yasu, Yuichi Muraki
9:30 AM - 9:42 AM JST(12:30 AM - 12:42 AM UTC)

[29-13-am01]Efficacy and safety of S-1 monotherapy as adjuvant chemotherapy for gastric cancer : a comparison considering surgical procedures

○Haruka Sumii1, Yusuke Yasuoka1, Miki Fujiwara1, Ryo Takada1, Yoko Takahashi1, Terutaka Hamaoka1 (1. Pharmacy Dept., NHO Fukuyama MC)
9:42 AM - 9:54 AM JST(12:42 AM - 12:54 AM UTC)

[29-13-am02S]Glucocorticoid tapering and risk of relapse in immune-related adverse events

○Yuto Kojima1, Mari Yokoi1, Daiki Hira1, Mirei Shirakashi2, Keisuke Umemura1, Keiko Ikuta1, Yurie Katsube1, Natsuki Imayoshi1, Yuki Shigetsura1, Shunsaku Nakagawa1, Kosaku Murakami3, Tomohiro Terada1 (1. Dept. Clinical Pharmacology and Therapeutics, Kyoto Univ. Hosp., 2. Dept. Rheumatology and Clinical Immunology, Grad. Sch. Med, Kyoto Univ., 3. CCII, Grad. Sch. Med, Kyoto Univ.)
9:54 AM - 10:06 AM JST(12:54 AM - 1:06 AM UTC)

[29-13-am03S]A chronopharmacology-based study evaluating the efficacy and safety of nivolumab + SOX therapy for gastric cancer

○Momoka Yamashita1, Natsuki Umiji1, Shuji Yamashita1, Momoko Meguro1, Nao Yamagishi1, Arisa Kurematsu1, Yoko Ino1,3, Tomoki Sugiyama4, Shinya Shimizu2, Hironori Fujii2, Hirotoshi Iihara2, Satoshi Aoyama3, Masahiro Yasuda1,3, Eiseki Usami1,4, Akio Suzuki1,2, Hideki Hayashi1,2 (1. Gifu Pharm. Univ., 2. Dept. Pharm., Gifu Univ. Hosp., 3. Dept. Pharm., Gifu Municipal Hosp., 4. Dept. Pharm., Ogaki Municipal Hosp.)
10:06 AM - 10:18 AM JST(1:06 AM - 1:18 AM UTC)

[29-13-am04S]Cumulative Incidence of Cancer Cachexia and Its Prognostic Implications in Patients with lung Cancer: A Retrospective Study Using EPCRC, AWGC and mGPS Criteria

○Natsuki Koketsu1, Misato Kani1, Hironori Fujii2, Chiemi Hirose2, Shino Ando2, Yunami Yamada2, Koichi Ohata2, Daichi Watanabe2, Hirotoshi Iihara2, Ryo Kobayashi1,2, Akio Suzuki1,2 (1. Gifu. Pharm. Univ., 2. Dept. Pharm. Gifu. Univ. Hosp)
10:18 AM - 10:30 AM JST(1:18 AM - 1:30 AM UTC)

[29-13-am05S]Study on Insoluble Microparticle Contamination Occurring on Opening Ampoules : Effect of Specifications and Manufacturer

○Yusuke Nagashima1, Akira Nakatsuma1, Yoichi Kawasaki1 (1. Kagawa Sch. Pharm. Sci., Tokushima Bunri Univ.)
10:30 AM - 10:42 AM JST(1:30 AM - 1:42 AM UTC)

[29-13-am06]Effects of green tea gargling on coronavirus disease-2019: A randomized controlled trial

○Yasue Kawai1, Yoshihiko Ito1, Takahiro J. Nakamura2, Daisuke Furushima3, Yuina Nakai1, Motoyasu Miura1, Shinya Uchida1, Keiko Unno1, Yoriyuki Nakamura1, Norikata Takuma4, Takatsugu Ikukawa5, Mitsuo Kimata5, Chika Tagata6, Makoto Kobayashi6, Masaki Ichitani6, Takanobu Takihara6, Hitoshi Kinugasa6, Ichiro Kato6, Hiroshi Yamada1 (1. Grad. Sch. Pharm. Sci., Univ. of Shizuoka,, 2. Sch. Agri. Meiji Univ., 3. Sch. Med. Kagoshima Univ., 4. Hakujujikai, 5. Seirei Hamamatsu General Hospital, 6. Central Research Institute, Ito En)
10:42 AM - 10:54 AM JST(1:42 AM - 1:54 AM UTC)

[29-13-am07]Survey on Oral Care Awareness Among Pharmacists in Pharmacies in Ehime Prefecture

○Takuma Matsumoto1,2,4, Natsumi Mori2, Yasushi Semba1,4, Mamoru Tanaka3,4, Shinichi Watanabe2,4 (1. Division of Pharmacy,NHO Shikoku Cancer Center, 2. College of Pharmaceutical Sciences, Matsuyama University, 3. Division of Pharmacy,Ehime University Hospital, 4. Ehime Pharmaceutical Association)
10:54 AM - 11:06 AM JST(1:54 AM - 2:06 AM UTC)

[29-13-am08S]Biotransformation assessment of therapeutic antibodies through comparison of quantification by mass spectrometry and ligand-binding assay

○Hiroki Oh1, Sho Masui1, Aoto Nakajima1, Kodai Yajima1, Takashi Shimada1,2, Atushi Yonezawa1 (1. Sch. Pharm. Sci., Keio Univ, 2. Shimadzu Corp.)
11:06 AM - 11:18 AM JST(2:06 AM - 2:18 AM UTC)

[29-13-am09S]Development of a mass spectrometry-based method for biotransformation analysis of bevacizumab in patient serum

○Kaori Wakuya1, Sho Masui1, Kodai Yajima1, Noritaka Hashii2, Akiko Ishii-Watabe2, Takashi Shimada1,3, Atsushi Yonezawa1 (1. Grad. Sch. Pharm. Sci., Keio Univ., 2. National Institute of Health Sciences, 3. Shimadzu Corp.)
11:18 AM - 11:30 AM JST(2:18 AM - 2:30 AM UTC)

[29-13-am10S]Exploring the Role of Pharmacists’ Referral Forms and MIBS-4 in Promoting Medical Consultation Among Patients With Migraine

○KOUTA HASUMI1,2, Ikumi Ito1, Hirotaka Katoh3, Μasakazu Ishii1 (1. Fac. Ρharm. Sci., Teikyo Heisei Univ., 2. Shinwa Pharmaceutical co., Ltd, 3. Kuramae Kato Medical Clinic)
Back to Category List